Artiva Biotherapeutics Inc

NAS:ARTV (USA)  
$ 12.60 +0.39 (+3.19%) 11:08 PM EST
At Loss
P/B:
1.52
Market Cap:
$ 306.05M
Enterprise V:
$ 164.91M
Volume:
26.46K
Avg Vol (2M):
67.08K
Trade In:
Volume:
26.46K
At Loss
Avg Vol (2M):
67.08K

Business Description

Artiva Biotherapeutics Inc
NAICS : 325412 SIC : 2834
ISIN : US04317A1079
Compare
Compare
Traded in other countries / regions
ARTV.USA
IPO Date
2024-07-19
Description
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials.
Name Current Vs Industry Vs History
Cash-To-Debt 9.8
Equity-to-Asset 0.89
Debt-to-Equity 0.07
Debt-to-EBITDA -0.26
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.71
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 72.87
9-Day RSI 60.12
14-Day RSI 55.05

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 11.33
Quick Ratio 11.33
Cash Ratio 11.03
Days Sales Outstanding 104.93

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -35.5
Shareholder Yield % 1.17

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -2344.75
Net Margin % -2189.39
FCF Margin % -2009.65
ROA % -45.85
ROIC % -147.38
ROC (Joel Greenblatt) % -264.42
ROCE % -54.2

Financials (Next Earnings Date:2024-11-29 Est.)

ARTV's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ARTV

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Artiva Biotherapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2.601
EPS (TTM) ($) -3.505
Beta 0
Volatility % 0
14-Day RSI 55.05
14-Day ATR ($) 1.207364
20-Day SMA ($) 11.77375
12-1 Month Momentum % 0
52-Week Range ($) 9.68 - 17.31
Shares Outstanding (Mil) 24.29

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Artiva Biotherapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Artiva Biotherapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Artiva Biotherapeutics Inc Frequently Asked Questions

What is Artiva Biotherapeutics Inc(ARTV)'s stock price today?
The current price of ARTV is $12.60. The 52 week high of ARTV is $17.31 and 52 week low is $9.68.
When is next earnings date of Artiva Biotherapeutics Inc(ARTV)?
The next earnings date of Artiva Biotherapeutics Inc(ARTV) is 2024-11-29 Est..
Does Artiva Biotherapeutics Inc(ARTV) pay dividends? If so, how much?
Artiva Biotherapeutics Inc(ARTV) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1